According to FutureWise analysis the Humanized Liver Mice Model Market in 2025 is US$ 130.2 million, and is expected to reach US$ 271.9 million by 2033 at a CAGR of 9.64%. Market growth is driven by the rising demand for reliable preclinical models in drug metabolism, hepatotoxicity studies, and research on infectious diseases like hepatitis and liver fibrosis. Humanized liver mice provide better translational relevance than traditional models, accelerating drug discovery and reducing clinical trial failures.
The humanized liver mice market is crucial for advancing the understanding of mammalian and human genome functions, as well as for developing effective therapies. As the demand for innovative research and practical outcomes increases, this global market is experiencing significant growth. However, high costs and technical complexities may pose challenges to market expansion.
Rapid advancements in technology, particularly in genetic engineering, have facilitated the creation of various genetically modified mouse models, including knock-out, knock-in, and transgenic mice. These developments are fostering lucrative opportunities within the market. Moreover, ongoing enhancements in technology are enabling the engineering of new immune-deficient mouse models, which are essential for exploring novel methods to improve the engraftment of human cells or tissues.
One of the notable breakthroughs in this field is the successful engraftment of human hepatocytes into mouse livers and human hematopoietic stem cells into mouse bone marrow. This groundbreaking achievement is anticipated to further drive the growth of the humanized liver mice market.
FutureWise Market Research has published a report that provides an insightful analysis of Humanized Liver Mice Model Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=254&type=requestsample
Humanized Liver Mice Model Market Segmentation:
By Application
- Pharmacokinetics Studies
- In-vivo Liver Toxicity Testing
- Drug Metabolism Studies
- Others
By Model
- uPA-SCID
- FRG KO Mice
- TK-NOG Mice
- Other Models
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CRO’s)
- Academic and Research Institutes
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Humanized Liver Mice Model Market:
- The Jackson Laboratory
- Crown Bioscience Inc. (JSR Life Science)
- Charles River Laboratories International, Inc.
- Taconic Biosciences, Inc.
- Ingenious Targeting Laboratory Inc.
- Trans Genic Inc., Ltd.
- GenOway
- Creative Animodel
- Horizon Discovery Group plc.
Recent developments by key players in Humanized Liver Mice Model Market:
Charles River Laboratories & Taconic Biosciences
Charles River has launched PBMC-engrafted humanized mouse models aimed at minimizing the onset of graft-versus-host disease (GVHD). This enhancement increases the effectiveness of these models in immuno-oncology and infectious disease research by delivering more reliable and reproducible results.
Taconic Biosciences
Taconic provides a humanized liver mouse model that replaces fourteen full-length mouse Cyp2c genes with an expression cassette that encodes human CYP2C9, regulated by a liver-specific promoter. This model is especially valuable for studying drug metabolism and liver toxicity.
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=254&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Humanized Liver Mice Model Market By Application, By Model, By End-User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
